2015 American Transplant Congress Archives - Page 11 of 170

A 10 Min “No-Touch” Time – Is It Enough in DCD? A DCD Animal Study

M. Sereinigg,¹ V. Stadlbauer,² T. Seifert-Held,³ F. Iberer,¹ P. Stiegler.¹
A 52-Week, Multicenter, Prospective, Observational, Non-Interventional, Open-Label Study to Assess the Effectiveness, Safety and Tolerability of Everolimus in Kidney Transplant Patients in Taiwan

S.-M. Wang,¹ P.-C. Lee,² J.-D. Lian,³ K.-H. Shu,⁴ S.-T. Wu,⁵ H.-C. Chen,⁶ C.-C. Huang,⁷ M.-S. Wu,⁸ Y.-C. Tian,⁹ Y.-J. Chiang,¹⁰ Y.-T. Chen,¹¹ H.-P. Wang.¹²
A Clinical Signature Surrogate of Histological Lesions to Avoid Unnecessary One Year Surveillance Biopsy After Renal Transplantation

E. Dantan, K. Renaudin, S. Brouard, A. Huneau, C. Paul, M. Giral.
A Common Gene Signature Across Multiple Studies Identifies Biomarkers and Functional Regulation in Tolerance to Renal Allograft

D. Baron,^1,2,3 G. Ramstein,⁴ M. Chesneau,^1,2,3 Y. Echasseriau,^1,2,3 A. Pallier,^1,2,3 C. Paul,^1,2,3 N. Degauque,^1,2,3 M. Hernandez-Fuentes,⁵ A. Sanchez-Fueyo,⁶ K. Newell,⁷ M. Giral,^1,2,3 J.-P. Soulillou,^1,2,3 R. Houlgatte,^8,9 S. Brouard.^1,2,3
A Comparative Analysis of Histological Scoring in Living Donor Renal Transplants from Donors Above and Below 60 Years of Age

A. Ghazanfar,^1,2 F. Kazmi,² A. Bagul,¹ M. Morsy,¹ J. Popoola.¹
A Comparison of Alemtuzumab and Antithymocyte Globulin Induction in High-Risk, Non-Sensitized African American Renal Transplant Recipients

M. Janusek,¹ S. Patel,² K. Galen,¹ P. West-Thilke,¹ E. Benedetti,¹ J. Thielke.¹
A Critical Analysis of the Impact of Socioeconomic Status on Racial Disparities in Kidney Transplantation

D. Taber, M. Gebregziabher, M. Hamedi, T. Srinivas, K. Chavin, P. Baliga, L. Egede.
A Cross-Organ Tissue Gene Expression Immune Signature Predates Chronicity

Y. Ng, O. Bestard, T. Sigdel, S.-C. Hsieh, T. Tran, M. Sarwal.
A Discrete Choice Experiment to Explore Patients' Preferences for Kidney Transplant Monitoring by Video-Conferencing

S. Brunet-Houdard,¹ M. Giral,² S. Gaboriau,² A. Meurette,² P. Daguin,² P. Tessier.³
A Distinct Glomerular Complement Deposition Pattern in Transplant Glomerulopathy

P. Verghese, R. Reed, A. Matas, Y. Kim.
A Gene Expression Assessment for Improving Disease Activity and Stage in Heart ABMR

A. Loupy, M. Racape, J. Reeve, J. Venner, S. Varnous, A. Gay, R. Guillemain, L. Hidalgo, C. Lefaucheur, X. Jouven, P. Bruneval, J. Duong, P. Halloran.
A Joint Survival Longitudinal Approach to Better Assess the Etiological Role of Risk Factors of Kidney Transplant Graft Failure

M.-C. Fournier,^1,2 E. Dantan,¹ Y. Foucher,^1,2 M. Giral.²
A Mouse Model of Pneumonitis Induced by Candida Albicans Infection After Allogeneic Skin Transplantation

A. Yang, Z. Guo, W. Ju, Y. Ma, A. Hu, Y. Chen, M. Chen, C. Wu, X. He.
A New Diagnostic and Pronostic Tool for Antibody Mediated Rejection in Kidney Transplantation: Intragraft Donor Specific Anti-HLA Antibodies Detection

J. Olagne,^1,2,3 A. Parissiadis,² S. Caillard,¹ N. Froelich,² L. Marcellin,³ C. Muller,¹ G. Gautier-Vargas,¹ P. Perrin,¹ L. Braun-Parvez,¹ F. Heibel,¹ C. Gachet,² B. Moulin.¹
A New Diagnostic Tool for Antibody Mediated Rejection in Heart and Lung Transplantation: Intragraft Donor Specific Anti-HLA Antibodies Detection

J. Olagne,^1,2,3 A. Parissiadis,² N. Froelich,² S. Caillard,¹ M.-P. Chenard,³ E. Epailly,⁴ H. Kremer,⁴ T. Degot,⁵ S. Hirschi,⁵ R. Kessler,⁵ B. Moulin.¹
A Non-Haematopoietic Erythropoietin Analogue, ARA 290, Inhibits Macrophage Activation and Prevents the Transplanted Islet Graft Damage

M. Watanabe,¹ T. Lundgren,¹ Y. Saito,¹ A. Cerami,² M. Brines,² C.-G. östenson,³ M. Kumagai-Braesch.¹
A Non-Invasive Urinary Common Rejection Module (uCRM) Gene Expression Score Enables Accurate Discrimination of Acute Rejection in Kidney Transplant Patients

O. Bestard,^1,2 T. Sigdel,¹ Y. Ng,¹ S.-C. Hsieh,¹ S. Roedder,¹ N. Dvorak,¹ T. Tran,¹ M. Sarwal.¹
A Noninvasive Diagnostic Test of Renal Allograft Rejection Using Urinary-Cell mRNA: A Comparison of Droplet Digital and Real-Time PCR

J.-W. Seo, H. Moon, A. Lee, Y.-W. Choi, Y. Kim, J.-Y. Moon, S.-H. Lee.
A Novel DSA Flow Cytometer Crossmatch (DSA-FXM) to Eliminate Ambiguous Auto- and Allo-FXM Results

G. Chen, L. Lin, D. Tyan.
A Novel Humanized Mouse Model for the Study of Induced Pluripotent Stem Cell-Derived Tissue Transplantation Tolerance and Function

M. Brown, I. Norman, Y. Zhou, J. Sullivan, W. Burlingham.
A Novel Maintenance Regimen With Calcineurin Inhibitor, MMF and Everolimus Initiated By Dual Induction Therapy With Anti-CD20/25 Antibodies in Renal Transplantation

N. Masaki, K. Iwado, I. Nakagima, S. Fuchinoue.
A Novel Post-Transplant High-Dose Cyclophosphamide-Based Regimen to Promote Immune Tolerance After VCA

G. Furtmüller,¹ M. Fryer,¹ B. Oh,¹ S. Ganguly,² J. Izzi,³ D. Cooney,¹ G. Raimondi,¹ W. Lee,¹ L. Luznik,² G. Brandacher.¹
A Novel Signaling Approach for the Prevention of Ischemia/Reperfusion Injury (IRI)

S. Khalid,¹ M. Haller,¹ K. Koziel,¹ M. Enthammer,¹ M. Hermann,² M. Thurner,¹ L. Kremser,³ H. Lindner,³ J. Troppmair.¹
A Novel Tool to Evaluate Coercion, Pressure, and Motivation in Potential Live Kidney Donors

A. Shaffer,¹ E. King,¹ J. Kahn,² L. Erby,³ D. Segev.¹
A Novel, Blocking Anti-CD40 Monoclonal Antibody Prolongs Non-Human Primate Renal Allograft Survival in the Absence of B-Cell Depletion Or Thromboembolic Events

J. Rush,¹ G. Wieczorek,¹ M. Audet,² M. Schneider,¹ P. Espie,³ L. Roth,¹ C. Heusser,¹ C. Bruns,¹ D. Patel,¹ F. Cordoba.¹
A Preliminary Study of Using Small Intestinal Submucosa Scaffolds Coated Islets and Mesenchymal Stem Cells to Built Artificial Pancreas

D. Wang, X. Ding, W. Xue, J. Zheng, X. Feng, X. Tian, Y. Li.
A Primary Cytomegalovirus Infection Post-Transplantation Has a Significant Impact on Circulating T Cells and Renal Allograft Function

R. Meijers,¹ N. Litjes,¹ A. Langerak,² C. Baan,¹ M. Betjes.¹
A Prospective and Randomized Study of Conversion from Tacrolimus to Cyclosporine A to Improve Glucose Metabolism in Patients With New-Onset Diabetes Mellitus After Renal Transplantation

K. Wissing,¹ D. Abramowicz,² L. Weekers,³ K. Budde,⁴ T. Rath,⁵ O. Witzke,⁶ D. Kuypers.⁷
A Prospective Comparison of the Completeness of Donor Kidney Biopsies

S. Ahmad,¹ E. Siskind,¹ C. Drachenberg,² J. Bromberg,¹ S. Niederhaus.¹
A Prospective Pilot Study Evaluating the Safety and Efficacy of Everolimus for the Prevention of CMV and BK Viral Infection (BKV) in Broadly Sensitized Kidney Transplant Recipients Following Desensitization With IVIG and Rituximab: Interim Analysis

J. Kahwaji,¹ S. Louie,¹ A. Vo,¹ J. Choi,¹ M. Toyoda,² S. Ge,² P. Wongsaroj,¹ A. Peng,¹ R. Villicana,¹ S. Jordan.¹
A Prospective Study of Renal Function and Histological Changes in Renal Transplant Recipients With Acute Clinical and Subclinical Rejection

S. Chen,¹ R. Mehta,¹ P. Sood,¹ P. Randhawa,² N. Shah,¹ C. Wu,¹ A. Tevar,³ S. Hariharan.¹
A Randomized Cross-Over Phase 3b Study of the Pharmacokinetics of Once-Daily Extended Release MeltDose® Tacrolimus (Envarsus® XR) Versus Twice-Daily Tacrolimus in African-Americans (ASERTAA)

J. Trofe-Clark,^1,2 D. Brennan,³ P. West-Thielke,⁴ M. Milone,⁵ M. Lim,² R. Bloom.²
A Randomized Study Comparing Parathyroidectomy Versus Cinacalcet to Treat Hypercalcemia in Kidney Allograft Recipients With Persistent Hyperparathyroidism

J. Cruzado,¹ V. Torregrosa,⁵ R. Mast,³ A. García-Barrasa,² O. Bestard,¹ E. Melilli,¹ J. Francos,² J. Torras,¹ C. Polo,¹ C. Gómez-Vaquero,⁴ J. Grinyó,¹ P. Moreno.²
A Relative Survival Model to Compare the Risk of Mortality in Patients Awaiting Kidney Transplantation Versus Already Transplanted Patients

M. Lorent,^1,2 K. Trébern-Launay,^2,1 C. Legendre,⁴ H. Kreis,⁴ G. Mourad,⁵ V. Garrigue,⁵ L. Rostaing,⁶ N. Kamar,⁶ M. Kessler,⁷ M. Ladrière,⁷ E. Morelon,⁸ F. Buron,⁸ M. Giral,^2,3 Y. Foucher.^1,2
A Retrospective Review of a Renal Sparing Protocol in Orthotopic Liver Transplantation

B. Pierce,² J. Levitsky,^1,3 M. McLaughlin,² C. Richardson.²
A Retrospective Study to Describe the Epidemiology and Outcomes of Opportunistic Infections After Solid Organ Transplantation

M. Helfrich,¹ P. Dorschner,¹ M. Ison.^1,2
A Single Center Comparison of Various BK Viremia Elimination Protocols

Y. Qazi, K. Lee, B. Duong, R. Dhawan, L. Shinn, L. Aguirre, C. Parke, C. Wong, S. Alexopoulos, D. Olson, M. Smogorzewski.
A Single Center Study of the Implementation Costs of the New Kidney Allocation System

C. Bostic, T. Stern, S. Niederhaus, J. Bromberg, D. Leeser.
A Single Center Study on Pregnacy and Allograf Function Outcomes Post Heart Transplant

S. Adams, M. Wigger.
A Single Centre Experience With the Living Donor Kidney Sharing Scheme: More Is Better!

K. Thomas, H. Crawshaw, S. Sinha, P. Mason, P. Harden, C. Winnearls, E. Sharples, S. Reddy, M. Sullivan, J. Gilbert, I. Quiroga, R. Ploeg, A. Vaidya, P. Friend.
A Specific Inhibitor of C1s, TNT003, Prevents Complement-Mediated Enhancement of Monocyte Adhesion to Endothelium in Response to HLA Antibodies

N. Valenzuela,¹ K. Thomas,¹ A. Mulder,² G. Parry,³ S. Parker,³ E. Reed.¹
A Tool for Predicting Long Term Risks of Kidney Donation

S. Reule,¹ R. Foley,¹ A. Matas,² H. Ibrahim.¹
A Tool to Estimate Probability of Outcomes on the Liver Transplant Waiting List

A. Hart,^1,2 D. Schladt,¹ J. Zeglin,¹ N. Salkowski,¹ S. Leppke,¹ W. Kim,^1,3 J. Lake,^1,4 A. Israni,¹ B. Kasiske,¹ J. Snyder.¹
AAV-Mediated TIMP-1 Gene Therapy Ameliorates Hepatic Ischemia/Reperfusion Injury

S. Duarte, T. Fujii, G. Lipshutz, R. Busuttil, A. Coito.
ABCB1 Haplotypes, Sex, Calcineurin Inhibitors and Lipid Profiles Post-Renal Transplant

C. Meaney,^1,2 R. Venuto,³ D. Brazeau,⁴ J. Consiglio,⁵ L. Cooper,¹ G. Wilding,⁵ K. Tornatore.^1,2,3
ABO Incompatible Simultaneous Liver-Kidney Transplant With Positive Crossmatch. A Case Report

T. Heffron,¹ C. Kulig,² P. Gauthier,² B. Bista,² S. Dionne,³ T. Pillen,¹ M. Asolati.¹
ABO-Incompatible Live Donor Kidney Transplants Inferior to ABO-Compatible Transplants, but Match Deceased Donor Results: Is Kidney Paired Donation the Answer?

J. Verbesey, M. Cooper, A. Gilbert, M. Grafals, P. Weems, J. Moore, S. Ghasemian, C. Nilubol, B. Javaid.
ABO-Incompatible Liver Transplantation for Severe Hepatitis B Patients

J. Zhou, W. Ju, X. Yuan, X. Jiao, D. Wang, X. Zhu, X. He.
Absence of Allograft TLR4 Receptor Signaling Attenuates Early Inflammation and Promotes Survival of Allografts Subjected to Prolonged Cold Ischemic Storage

N. Kohei,¹ T. Tanaka,¹ H. Tsuda,¹ D. Kish,¹ K. Tanabe,² R. Fairchild.¹
Absence of Low-Grade Proteinuria Is Associated With Improved Outcomes in Patients With Worse 3 Month Graft Function in Renal Transplantation

A. Seitz,¹ A. Cherukuri,² R. Baker.¹
Absence of Nucleotide-Binding Oligomerization Domain-Containing Protein 1 and 2 Modifies Adaptive Immune Responses

S. Kasimsetty, A. Shigeoka, D. McKay.
Accurate Prediction of High-Resolution HLA-A, -B, -C, -DRB1 and -DQB1 Typing and Low-Resolution HLA-DQA1 Typing by Haplotype Analysis

A. Jaramillo,¹ R. Vaidya,² M. Pando,³ S. Gaitonde.⁴
Acoustic Radiation Force Impulse Measurement in Renal Transplantation

J. Lee,¹ J. Lee,¹ A.-l. Lee,² B. Ma,³ Y. Oh,⁴ K. Huh,¹ M. Kim,¹ S. Kim,¹ Y. Kim,¹ D. Joo.¹
Activated Protein C Treatment Protects Steatotic and Non-Steatotic Livers Under Ischemia–Reperfusion Injury in Different Manner

A. Matsuda, N. Kuriyama, H. Kato, Y. Azumi, M. Kishiwada, S. Mizuno, M. Usui, S. Isaji.
Activated T Regulatory Cells Escape Death by Increasing Cytoplasmic Serine Protease Inhibitor 6 (SPI6)

A. Radwan, M. Uehara, P. Lukyanchykov, L. Riella, A. Chandraker, R. Abdi, J. Azzi.
Activation and Sequestration of Platelets During Xenogeneic GalTKO.hCD46 Pig Lung Perfusion Is Primarily Mediated By GPIb, GPIIb/IIIa, and VWF

L. Burdorf,¹ A. Riner,¹ A. Shah,¹ E. Schwartz,¹ K. Quinn,¹ E. Kang,¹ E. Sievert,¹ E. Rybak,¹ D. Harris,¹ T. Zhang,¹ D. Parsell,¹ X. Cheng,¹ G. Braileanu,¹ S. De Meyer,² I. Salles,² H. Deckmyn,² C. Phelps,³ D. Ayares,³ R. Pierson III,¹ A. Azimzadeh.¹
Activation of FXR Protects Against Liver Ischemia and Reperfusion Injury (IRI) in Mice Via the PI 3-Kinase/Akt (PI3K/Akt) Pathway

J. Zhang,¹ X. Liu,² D. Li,¹ H. Dai,¹ J. Zhang,¹ T. Lu,¹ Q. Xia.¹
Activation of Th17 and Chronic Renal Allograft Rejection in Nonhuman Primates

K. Hotta, A. Aoyama, P. Putheti, Y. Yamada, T. Ohura, R. Colvin, B. Cosimi, G. Benichou, T. Strom, T. Kawai.
Active Immunization in Patients Transplanted for Hepatitis B Virus Related Liver Diseases: A Preliminary Report of a Prospective Study

W. Ju, A. Yang, Z. Guo, Q. Ren, D. Wang, A. Hu, Y. Ma, H. Jin, X. Zhu, X. He.
Acute Kidney Injury After Lung Transplantation – Incidence, Risk Factors and Mechanisms

F. Gueler,¹ G. Warnecke,⁵ M. Peperhove,² M.-S. Jang,¹ C. Schroeder,³ S. Tewes,² B. Wiese,⁶ C. Fegbeutel,⁵ R. Lichtinghagen,⁷ B. Jüttner,⁸ F. Wacker,² D. Hartung,² B. Akerstrom,⁴ M. Gram,⁴ H. Haller,¹ A. Haverich,⁹ K. Hueper.²
Acute Kidney Injury and Outcome After Cardiac Transplantation

G. Fortrie,¹ O. Manintveld,² K. Caliskan,² M. Betjes.¹
Acute Kidney Injury in Kidney Transplant Patients According to the KDIGO Criteria

T. Filiponi, A. Silva-Filho, E. Tonato, L. Requiao-Moura, A. Matos, E. Arruda, R. Chinen, L. Pires, M. Durão Junior.
Acute Kidney Injury in the Early Post Kidney Transplant Period: Frequency, Etiology and Significance

B. Kiberd,¹ S. Cimen,¹ K. Tennankore.²
Acute Kidney Injury in the MELD Era of Liver Transplantation. Are Calcineurin Inhibitors So Problematic for Renal Function?

R. Ciria Bru, I. Gómez Luque, M. Cortés Cerisuelo, P. López Cillero, J. O'Grady, M. de la Mata, N. Heaton, J. Briceño Delgado.
Addressing Low Live Kidney Donation Rates in African Americans through the Live Donor Champion Program

E. King,¹ J. Garonzik-Wang,³ M. Bowring,¹ K. Kumar,¹ D. Segev.^1,2
Adherence Time-Profiles of Renal Transplant Patients During the Three First Years Post-Transplantation

C. Villeneuve,^1,2,3 C. Monchaud,^1,2,3 M. Essig,^2,4 M.-L. Laroche,^1,3 A. Coubret,¹ I. Lacroix,⁵ S. Bouchet,^6,7,8 D. Fruit,^1,2,3 P. Merville,⁹ N. Kamar,^10,11,12 P. Marquet,^1,2,3 A. Rousseau.^2,13
Adoptive Immunotherapy Using Activated NK Cells Ameliorates the FcγRIIIa Gene Polymorphism-Associated Susceptibility to Post Transplant Bloodstream Infection

S. Shimizu, Y. Tanaka, H. Tazawa, S. Verma, H. Ohdan.
Adoptive Immunotherapy With Liver Allograft-Derived NK Cells Improves Recurrence-Free Survival After Living-Donor Liver Transplantation in Patients With Hepatocellular Carcinoma

N. Tanimine, Y. Tanaka, K. Ishiyama, M. Ohira, S. Shimizu, T. Yano, H. Ohdan.
Adoptive Transfer of T Cell Receptor-Transgenic (TCR-Tg) Cells Alters Endogenous Immune Responses During Acute Rejection

M. Miller, M. Daniels, Y. Wang, D. Yin, A. Chong, M.-L. Alegre.
Advanced Imaging Modalities for Hepatocellular Carcinoma: Is MRI With Eovist Really Better?

M. Chen, H. Reich, M. Uffenheimer, Y. Nasseri, A. Annamalai.
Adverse Events of Maintenance Immunosuppression Following Kidney Transplantation Reported in Randomized Controlled Trials: A Systematic Review

M. Howell,^1,2 R. Yeo,² A. Tong,^1,2 J. Craig,^1,2 K. Howard,² G. Wong.^2,3
African American Race Is an Independent Risk Factor for Cytomegalovirus Infection in Renal Transplant Recipients on Low-Dose Valganciclovir Prophylaxis

S. Patel, S. Kuten, J. Loucks-DeVos, R. Knight, A. Gaber.
Age Should Not Be Considered a Contraindication for Living Kidney Donation

D.-A. Moutzouris, R. Charif, J. Galliford, J. McDermott, H. Dulku, H. Orr, D. Taube, M. Loucaidou.
Age-Dependent Decline in Glomerular Filtration Rate: A US Population-Based Study

P. Udompap, N.-Y. Heo, A. Mannalithara, W. Kim.
Age-Specific Graft Failure Rates in Pediatric Heart Transplant Recipients

B. Foster,¹ M. Dahhou,¹ X. Zhang,¹ V. Dharnidharka,² V. Ng,³ J. Conway.⁴
Age-Specific Graft Failure Rates in Pediatric Liver Transplant Recipients

B. Foster,¹ M. Dahhou,¹ X. Zhang,¹ V. Dharnidharka,² J. Conway,³ V. Ng.⁴
Age, Race and Socioeconomic Factors Have a Strong Influence on Candidates Finding a Living Donor Kidney

G. Vranic, A. Nishio Lucar, D. Keith.
Aging Enhances Immunosuppressives Capacities of Tacrolimus By Functional Changes of CD4+ T-Cells

F. Krenzien,¹ M. Quante,¹ A. ElKhal,¹ H. Uehara,¹ R. Abdi,² B. Slegtenhorst,¹ H. Biefer,¹ S. Tullius.¹
ALDH Expression in Facilitating Cells Plays a Critical Role in Regulatory T Cell Induction and GVHD Prevention

H. Xu,¹ T. Miller,¹ Y. Huang,¹ S. Ildstad.^1,2
Aldosterone Acts Directly On T Cells, and Promotes Production of Inflammatory Cytokines

J. Bagley, S. Begum, J. Iacomini.
Alemtuzumab Dose Adjusted for Weight Reduces Infection Post-Renal Transplantation

C.-H. Yoon, M. Willicombe, C. Jogia, R. Charif, J. Galliford, A. McLean, D. Taube.
Alemtuzumab in Elderly Renal Transplant Recipients Is Not Associated With a Poor Outcome

D.-A. Moutzouris, L. Koizia, M. Willicombe, R. Corbett, N. Duncan, J. Galliford, A. McLean, D. Taube.
Alemtuzumab Induction Has Been Safe in the United Kingdom and Achieves Long-Term Steroid Avoidance in More Than 80% of Low Risk Renal Transplant Recipients

A. Seitz,¹ M. Robb,³ S. Balasubramanian,¹ A. McLean,² D. Taube,² R. Johnson,³ R. Baker.¹
Alemtuzumab Induction Is Associated With a Lower Risk of Early Rehospitalization After Kidney Transplant

G. Dube,¹ D. Tsapepas,² Y. Coppleson,³ L. Ratner,⁴ D. Cohen,¹ S. Mohan.¹
Alemtuzumab Induction Is Associated With Higher Risk of Polyomavirrus Associated Nephropathy (PVAN) in Kidney Transplant Recipients

H. Wadei,¹ H. Saull,² C. Enderby,² M. Mai,¹ M. Prendergast,¹ T. Gonwa.¹
Alemtuzumab Induction Is Protective Against Acute Rejection in Kidney Recipients With Subtherapeutic Tacrolimus Concentrations

K. Szempruch, R.-A. Lee, R. Dupuis, J. Deyo, T. Kozlowski.
Allo-Stimulated Interferon-γ Release and Natural Killer Cell Function Defines and Risk Stratifies Cancer Development in Kidney Transplant Recipients Who Have Cancer Post-transplantation

C. Hope,^1,2 A. Fuss,^1,2 W. Hanf,¹ P. Coates,^1,2 P. Heeger,³ R. Carroll.^1,2
Alloantibody-Dependent Macrophage-Mediated Hepatocellular Damage Is Dependent on FcγRI, FcγRIII, and Reactive Oxygen Species

J. Zimmerer, X. Liu, A. Blaszczak, C. Wright, T. Pham, G. Bumgardner.
Allogeneic Mature Human Monocyte-Derived Dendritic Cells Generate Superior Alloreactive Regulatory T Cells in an IL-2-Independent Manner

N. Litjens,¹ K. Boer,¹ J. Zuijderwijk,¹ M. Klepper,¹ A. Peeters,¹ E. Prens,² W. Verschoor,¹ R. Kraaijeveld,¹ Z. Ozgur,³ M. van den Hout-van Vroonhoven,³ W. van IJcken,³ C. Baan,¹ M. Betjes.¹
Allogeneic Monocyte–Endothelial Cell Interaction Plays a Critical Role in Initiating Early Pro-Fibrosis Responses

E. Gall, H. Xu, K. Samy, A. Kirk.
Allograft Class II MHC and CD40 Expression Are Required for Endogenous Memory CD8 T Cell Proliferation in Cardiac Allografts Subjected to Prolonged Cold Ischemic Storage

T. Tanaka,^1,2 H. Tsuda,^1,3 N. Kohei,^1,4 D. Kish,¹ W. Baldwin,¹ A. Valujskikh,¹ R. Fairchild.¹
Allograft Enterectomy as a Life-Saving Procedure and Salvage for Retransplantation

S. Nagai, R. Mangus, B. Ekser, C. Kubal, J. Fridell, A. Tector.
Allograft Pancreatectomy: Indications and Outcomes

S. Nagai, J. Powelson, R. Mangus, J. Fridell.
Alloimmune Regulation and Long-Term Allograft Survival Induced by Short-Term Administration of Chinese Medicine Cornus Officinalis and Cuscuta Sinensis Lam

Z. Dai, Y. Zeng, X. Liu, Z. Chuan.
Alpha-Fetoprotein as a Modifier of Anatomic Criteria for Transplantation of HCC Patients

A. Daoud,^1,3 M. Ghobrial,¹ L. Teeter,² E. Graviss,² E. Asham,¹ S. Burroughs,¹ A. Saharia,¹ C. Mobley,¹ S. Mogawer,³ A. Sholkamy,³ M. Elshazly,⁴ M. Boktour,¹ A. Gaber.¹
Alterations in Peripheral Blood B Cell Subpopulations in Kidney Transplant Recipients With DSA

B. Ramaswami,¹ R. Ippolito,² B. Elinoff,¹ M. Marrari,³ K. Hadi,¹ C. Macedo,¹ D. Metes,¹ A. Shields,⁴ R. Alloway,⁵ A. Zeevi,³ F. Lakkis,¹ E. Woodle,⁴ G. Chalasani.^1,2
Altered Intestinal Microbiome as a Potential Biomarker for Failed Immune-Regulation in Autoimmune Type 1 Diabetes Mellitus

P. Chhabra,¹ A. Spano,² D. Bowers,¹ M. Wu,² L. Langman,¹ M. Timko,² K. Brayman.¹
An Analysis of Health-Related Quality of Life in Liver Transplantion for Hepatocellular Carcinoma

C. Kensinger, H. O'Dell, D. LaNeve, L. Simmons, I. Feurer, D. Moore.
An Economic Analysis of Tolerance Induction for Two-Haplotype Match Kidney Living Donor Transplant Recipients

K. Erickson,¹ W. Winkelmayer,² R. Lowsky,¹ J. Scandling,¹ S. Strober.¹
An Investigation of 12 Cases of Membranous Nephropathy of the Donor Origin Accidentally Detected by 0-h Renal Biopsy During Kidney Transplantation

K. Unagami,¹ D. Toki,¹ M. Okumi,¹ H. Ishigooka,¹ K. Tsujimura,¹ T. Kanzawa,¹ K. Omoto,¹ H. Ishida,¹ K. Nitta,² K. Tanabe.¹
An Orchestrated Sequence of Innate and Adaptive Immune Responses Is Associated With Rejection After Pediatric Liver Transplantation

C. Falk,¹ I. Goldschmidt,² F. Mutschler,² C. Neudörfl,¹ J. Keil,¹ K. Daemen,¹ F. Lehner,³ R. Mikolajzcyk,⁴ A. Karch,⁴ U. Baumann.²
Analysis of Causes of Graft Loss Among Kidney Transplant Patients Receiving Tacrolimus Vs Cyclosporine

M. Kamel,¹ M. Posadas Salas,¹ D. Taber,² M. Kadian,¹ M. Salazar,¹ P. Mohan,¹ T. Srinivas.¹
Analysis of In-Vitro Effects of Immunosuppression on NK Cell Subsets in the Presence of Cytomegalovirus

S. Keshwani, D. Kumar, S. Han, S. Husain, V. Ferreira, P. Ashton, A. Humar.
Analysis of Patient Refusals for Transplantation

A. Reeves-Daniel,¹ A. Palanisamy,¹ G. Orlando,² J. Rogers,² G. Russell,¹ A. Farney,² J. Burkart,¹ R. Stratta,² B. Freedman.¹
Analysis of the Temporal Evolution of Causes of Graft Loss Among Kidney Transplant Recipients in a US Southern State

M. Kadian,¹ M. Posadas Salas,¹ M. Kamel,¹ D. Taber,² M. Salazar,¹ P. Mohan,¹ T. Srinivas.¹
Analytic Morphomics May Identify Risk Factors for New Onset Diabetes After Kidney Transplantation

D. Cron,¹ M. Terjimanian,¹ J. Augustine,² D. Cote,³ K. Noon,³ V. Vaughn,⁴ S. Wang,¹ M. Englesbe,¹ K. Woodside.³
Angiopoietin-2 Associates With Graft Failure and Mortality in Renal Transplant Recipients

W. Westendorp,¹ C. Keyser,² E. van den Berg,² C. Krikke,¹ H. van Goor,³ S. Bakker,² H. Leuvenink.¹
Angiotensin Receptor Antibody IgG1 Subclass Predicts Accelerated Graft Loss in Those Kidney Transplant Recipients Who Develop Biopsy Proven Transplant Glomerulopathy Irrespective of the Presence Or Absence of Donor Specific Anti HLA Antibodies

R. Carroll,¹ A. Phillippe,² D. Dragun,² T. Coates.¹
Anti-Apoptotic But Not Mitotic Effects of 3,3',5-triiodo-l-thyronine in the Liver of Brain Dead Rats

A. van Erp,¹ R. Rebolledo,² J. Wiersema-Buist,¹ P. Ottens,¹ H. Leuvenink,¹ P. Romanque.²
Anti-BTLA Antibody (6B2) Induced Prolongation of Fully MHC-Mismatched Murine Cardiac Allograft and Generation of Foxp3+ Regulatory T Cells

M. Uchiyama,^1,2,3 E. Yin,^3,4 X. Jin,^3,5 T. Shimokawa,¹ H. Yagita,² M. Niimi.³
Anti-CD122 + Costimulation Blockade Prolongs Allograft Survival

D. Mathews,¹ L. Higginbotham,¹ Y. Dong,¹ C. Breeden,¹ C. Larsen,¹ J. Tso,² A. Adams.¹
Anti-Donor T-Cell Immunity Is a Continuum Immune Process Favouring Subclinical Rejection After Kidney Transplantation

E. Crespo,¹ M. Lucia,¹ J. Cruzado,^1,2 S. Luque,¹ E. Melilli,² A. Manonelles,^1,2 N. Sala,² J. Grinyó,^1,2 O. Bestard.^1,2
Anti-LG3 Antibodies Aggravate Ischemia-Reperfusion Injury

B. Yang,¹ K. Hamelin,¹ L. Pomerleau,¹ J. Peng,¹ J. Tremblay,¹ N. Patey,² M.-J. Hébert.¹
Anti-Thymocyte Globulin Induction in Infected Mechanical Circulatory Support Patients: Is It Safe?

G. Jamero, J. Moriguchi, L. Czer, M. Kittleson, S. Siddiqui, F. Liou, D. Arman, L. Lam, D. Chang, P. Zakowski, J. Kobashigawa.
Antibodies Directed Against HLA-DQ Are Significantly Associated to Complement Activation In Vitro

J. Arreola-Guerra, A. de Santiago, A. Arvizu, N. Gonzalez-Tableros, M. Lopez, M. Vilatoba, L. Morales-Buenrostro, J. Alberu, N. Castelan.
Antibody Response Following Influenza Vaccination in Renal Transplant Recipients

M. Mujtaba, B. Book, A. Sharfuddin, A. Khalil, S. Vaishnav, E. Wiebke, M. Yaqub, D. Mishler, T. Taber.
Antibody-Induced Platelet Activation Increases Allograft Hyaluronan Fragmentation

H.-H. Kuo,¹ R. Fan,¹ N. Dvorina,¹ C. De La Motte,² W. Baldwin.¹
Antibody-Mediated Rejection Is Associated With Higher Serum Levels of CXCL13 and CCL21 in Renal Transplant Patients and Altered By Bortezomib/Rituximab Treatment

M. Duerr,¹ K. Daemen,² J. Keil,² K. Budde,¹ C. Falk.²
Antibody-Mediated Rejection of Renal Allografts by CCR5-/- Mice Does Not Require CD8 T Cells

N. Kohei,¹ T. Tanaka,¹ H. Tsuda,¹ N. Dvorina,¹ K. Tanabe,² W. Baldwin,¹ R. Fairchild.¹
Antithymocyte Globulin-Induced Platelet Hypercoagulability Is a Consequence of Complement Activation and Microvesicle Release

D. Zecher,^1,4 A. Cumpelik,¹ D. Tsakiris,² M. Dickenmann,³ J. Schifferli.¹
APOL1 Risk Alleles in Live and Deceased Kidney Donors Are Associated With Shorter Renal Allograft Survival

M. Doshi,¹ M. Goggins,² S. Norman,³ S. Ho,⁴ C. Winkler,⁵ J. Kopp.⁶
Application of Second Generation Sequencing and AlloAntibody Screening to the Organ Transplantation Arena

B. Keating,¹ Y. Li,¹ K. Olthoff,¹ J. Wang,² A. Shaked.¹
Application of the Clavien Classification of Surgical Complications to Robotic Kidney Transplantation

R. Garcia Roca, C. Martinez Parra, I. Tzvetanov, H. Jeon, E. Benedetti, J. Oberholzer.
Aquaporin 4 Blockade Is a Novel Strategy Targeting Ischemia/Reperfusion Injury in Heart Transplantation

K. Ayasoufi,¹ N. Kohei,¹ G. Farr,² P. McGuirk,² M. Pelletier,² R. Fairchild,¹ A. Valujskikh.¹
Are AT1R Antibodies as Dangerous as HLA-DSAs in Renal Allografts?

E. Cuevas, J. Arreola-Guerra, E. Hernandez-Mendez, I. Salcedo, M. Vilatoba, A. Contreras, A. Sanchez-Cedillo, J. Ramirez, D. de Rungs, J. Granados, L. Morales-Buenrostro, J. Alberu.
Are DQA Antibodies Real?

J. Jones, D. Lucas, M. Leffell, A. Zachary.
Are Living Kidney Donors Who Apply Via a Web-Based Screening Application as Likely to Be Evaluated and Donate as Compared to Phone Applicants?

H. Schaefer, M. Tanaka, I. Feurer, A. Dreher, P. Newbern, D. Moore.
Are We Missing Cardiovascular Disease in Children Awaiting Liver Transplant?

C. Villa,¹ E. Hahn,¹ J. Bucuvalas,² K. Campbell,² R. Hirsch,¹ M. Lake,² A. Lorts.¹
Arterial Blood Pressure at Time of Liver Transplant (LT) Evaluation Correlates With Kidney Biopsy Findings in LT Candidates With Renal Dysfunction

H. Wadei, A. Peguero, A. Alsaad, M. Mai, K. Oshel, T. Gonwa, C. Taner, A. Keaveny.
Arterial Hypertension and the Use of Antihypertensive Medication in Pediatric Renal Transplant Patients: An Analysis of the CERTAIN Registry

R. Sugianto,¹ E. Wühl,² B. Schmidt,¹ S. Geyer,³ K. Krupka,² B. Höcker,² B. Tönshoff,² A. Melk.¹
Arteriovenous Fistulas/Grafts for Patients With Intestinal Failure: Innovation or Insanity?

G. Vrakas, A. Vaidya, J. Gilbert.
Artificial Neural Networks in Kidney Allocation in Patients With Dual Organ (Liver-Kidney) Failure

V. Rao,¹ R. Behara.²
ASKP1240 in De Novo Kidney Transplant Recipients

R. Harland,¹ G. Klintmalm,² H. Yang,³ S. Jensik,⁴ T. Shah,⁵ P. West-Thielke,⁶ F. Shihab,⁷ W. Zhang,⁸ V. Santos,⁸ R. Tainaka,⁸ X. Wang,⁸ R. First,⁸ J. Holman.⁸
Assessing Pre-Vaccination Cytokine Levels to Predict Immunogenicity to Seasonal Trivalent Influenza Vaccine in Solid Organ Transplant Recipients

M. Fernandez-Ruiz, A. Humar, S. Keshwani, S. Husain, D. Kumar.
Assessing Transplant Attitudes: Understanding Minority Men's Perspectives on the Multifarious Barriers to Organ Donation

B. Hinck, B. Naelitz, B. Jackson, M. Howard, A. Nowacki, C. Modlin.
Assessment of Actual Pediatric Organ Donation Potential: Neurologic and Circulatory Determination of Death at a Children's Hospital

C. Aguayo,¹ E. Bennett,² J. Sweney,² C. Myrick,¹ S. Bratton.²
Assessment of Bleeding and Thrombosis in Responders and Initial Non-Responders to Aspirin After Continuous-Flow Left Ventricular Assist Device Placement

C. Floroff, K. Rieger, T. Veasey, S. Strout, H. Meadows, M. Stroud, J. Toole, M. Brisco, J. Cook, J. Lazarchick, W. Uber.
Assessment of Circulating HLA-Specific Alloreactive Memory B Cells Reveals Surreptitious Immunized Kidney Transplant Recipients at High Risk of Antibody-Mediated Rejection

M. Lúcia,¹ S. Luque,¹ E. Crespo,¹ J. Cruzado,^1,2 E. Melilli,² J. Martorell,³ J. Torras,^1,2 S. Gil-Vernet,² J. Grinyo,^1,2 O. Bestard.^1,2
Assessment of Eating Disorders in Altruistic Organ Donor Candidates: Pitfalls, Red Flags and Practical Suggestions

R. Jaiswal, J. Gordon-Elliott, F. Desrosiers.
Assessment of Hospital Readmissions After Mechanical Circulatory Support

F. Arabia, M. Kittleson, L. Czer, J. Hajj, E. Passano, F. Liou, S. Siddiqui, D. Chang, J. Kobashigawa, J. Moriguchi.
Assessment of IgG Subclass Significance for Early Graft Rejection and Long-Term Survival in HLA-Antibody Incompatible Renal Transplantation: Multivariate Approach

N. Khovanova,¹ D. Lowe,² S. Daga,^1,3 T. Shaikhina,¹ N. Krishnan,³ D. Mitchell,¹ D. Zehnder,¹ D. Briggs,² R. Higgins.³
Assessment of Renal Function in Kidney Transplant Recipients Through Therapeutic Drug Monitoring of Vancomycin

A. Thamer, N. Elias, C. Varughese, T. Gift, J. Fishman, S. Shao.
Assessment of Viral-Specific Memory T Cell Responses and Infection Rates in HLA-Sensitized (HS) Kidney Transplant Patients (Tx Pts) Treated With Everolimus & Low-Dose Tacrolimus (Eve/Tac)

S. Ge, J. Kahwaji, M. Chu, A. Karasyov, M. Castro, E. Hayrapetyan, D. Lovato, D. Thomas, J. Choi, S. Louie, A. Vo, S. Jordan, M. Toyoda.
Association Between Histological Abnormalities in Time-Zero Renal Biopsies and Post-Donation eGFR in Live Donors

L. Fahmy, A. Massie, B. Orandi, S. Bagnasco, J. Alejo, B. Boyarsky, S. Anjum, R. Montgomery, N. Dagher, D. Segev.
Association Between Polymorphisms of PPM1E Gene and Tumor Size of Hepatocellular Carcinoma Patients

M.-S. Park,¹ S.-K. Kim.²
Association Between the Timed Up and Go Test and Waitlisting for Kidney Transplantation

M. Chiles,¹ K. Foley,¹ R. Crew,¹ G. Dube,¹ H. Morris,¹ S. Patel,² J. Camacho,² D. Cohen,¹ L. Ratner,² S. Mohan.¹
Association of De Novo Antibody-Mediated Rejection and Increased Hospital Costs Following Kidney Transplant in Immunologically Low-Risk Patients

S. Kulkarni,¹ I. Hall.²
Association of IP-10 With Poor Islet Graft Function After Total Pancreatectomy With Islet Autotransplantation

M. Kanak,¹ M. Lawrence,² F. Kunnathodi,² G. Yoshimatsu,² R. Shahbazov,² M. Takita,² M. Levy,³ B. Naziruddin.³
Association of Pulmonary Hypertension at Kidney Transplant Evaluation and Subsequent Outcomes Following Transplantation

Y.-L. Lai,¹ H. Wasse,² W. Kim,³ R. Patzer.^1,4
Association of Transplant Volume and Survival in Pediatric Kidney Transplants

W. Cherikh,¹ A. Wilk,¹ C. Flavin,¹ E. Brewer.²
Associations Between Deceased-Donor Urine Biomarkers of Kidney Injury and 6-Month Kidney Transplant Function

C. Parikh, I. Hall, M. Doshi, B. Schroppel, F. Weng, R. Hasz, P. Murray, V. Rao, H. Thiessen-Philbrook, J. Ficek, P. Reese.
Associations Between Sirolimus Use and Outcomes After Liver Transplant for Hepatocellular Carcinoma

E. Yanik,¹ S. Chinnakotla,² A. Israni,^2,3 J. Snyder,^2,3 S. Gustafson,³ E. Engels.¹
Associations of Pre-Transplant Prescription Narcotic Use With Clinical Complications After Kidney Transplantation

N. Lam,¹ M. Schnitzler,² J. Tuttle-Newhall,² H. Xiao,² D. Axelrod,³ D. Brennan,⁴ V. Dharnidharka,⁴ M. Nazzal,² K. Lentine.²
Attenuating Racial Disparities in Kidney Transplantation Through the Use of Potent Immunosuppression Regimens

D. Taber, M. Gebregziabher, N. Pilch, T. Srinivas, K. Chavin, P. Baliga, L. Egede.
Attitudes and Beliefs About Organ Donation: Focus Group Study in Arabic-Speaking Communities in Australia

A. Ralph,^1,2 A. Alyami,^3,4 R. Allen,^3,4 K. Howard,¹ J. Craig,^1,2 S. Chadban,^3,4 M. Irving,^1,2 A. Tong.^1,2
Avoiding Futility in Simultaneous Liver-Kidney Transplantation (SLKT): Analysis of 331 Consecutively Listed Patients

K. Lunsford, A. Bodzin, D. Reino, A. Zarrinpar, F. Kaldas, H. Gritsch, J. Veale, G. Lipshutz, D. Farmer, G. Danovitch, H. Yersiz, J. Hiatt, R. Busuttil, V. Agopian.